A Randomized Noninferiority Trial of Wearing Adjustable Glasses versus Standard and Ready-made Spectacles among Chinese Schoolchildren: Wearability and Evaluation of Adjustable Refraction III.


Journal

Ophthalmology
ISSN: 1549-4713
Titre abrégé: Ophthalmology
Pays: United States
ID NLM: 7802443

Informations de publication

Date de publication:
01 2020
Historique:
received: 21 03 2019
revised: 31 07 2019
accepted: 04 08 2019
pubmed: 24 9 2019
medline: 18 4 2020
entrez: 24 9 2019
Statut: ppublish

Résumé

To compare wear of standard, adjustable, and ready-made glasses among children. Randomized, controlled, open-label, noninferiority trial. Students aged 11 to 16 years with presenting visual acuity (VA) ≤6/12 in both eyes, correctable to ≥6/7.5, subjective spherical equivalent refractive error (SER) ≤-1.0 diopters (D), astigmatism and anisometropia both <2.00 D, and no other ocular abnormalities. Participants were randomly allocated (1:1:1) to standard glasses, ready-made glasses, or adjustable glasses based on self-refraction. We recorded glasses wear on twice-weekly covert evaluation by head teachers (primary outcome), self-reported and investigator-observed wear, best-corrected visual acuity (BCVA) (not prespecified), children's satisfaction, and value attributed to glasses. Proportion of glasses wear on twice-weekly covert evaluation by head teachers over 2 months. Among 379 eligible participants, 127 were allocated to standard glasses (mean age, 13.7 years; standard deviation [SD], 1.0 years; 54.3% were male), 125 to ready-made (mean age, 13.6; SD, 0.83; 45.6%), and 127 to adjustable (mean age, 13.4 years; SD, 0.85; 54.3%). Mean wear proportion of adjustable glasses was significantly lower than for standard glasses (45% vs. 58%; P = 0.01), although the adjusted difference (90% confidence interval [CI], -19.0% to -3.0%) did not meet the prespecified inferiority threshold of 20%. Self-reported (90.2% vs. 84.8%, P = 0.64) and investigator-observed (44.1% vs. 33.9%, P = 0.89) wear did not differ between standard and adjustable glasses, nor did satisfaction with (P = 0.97) or value attributed to study glasses (P = 0.55) or increase in quality of life (5.53 [SD, 4.47] vs. 5.68 [SD, 4.34] on a 100-point scale, P > 0.30). Best-corrected visual acuity with adjustable glasses was better (P < 0.001) than with standard glasses. Change in power of study lenses at the end of the study (adjustable: 0.65 D, 95% CI, 0.52-0.79; standard, 0.01 D; 95% CI, -0.006 to 0.03, P < 0.001) was greater for adjustable glasses, although interobserver variation in power measurements may explain this. Lens scratches and frame damage were more common with adjustable glasses, whereas lens breakage was less common than for standard glasses. Proportion of wear was lower with adjustable glasses, although VA was better and measures of satisfaction and quality of life were not inferior to standard glasses.

Identifiants

pubmed: 31543351
pii: S0161-6420(19)31879-2
doi: 10.1016/j.ophtha.2019.08.002
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT02529540']

Types de publication

Comparative Study Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

27-37

Informations de copyright

Copyright © 2019 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Auteurs

Congyao Y Wang (CY)

Department of Ophthalmology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong Province, China.

Guoshan Zhang (G)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Centre, Sun Yat-sen University, Guangzhou, Guangdong Province, China.

Bobby Tang (B)

Centre for Public Health, Queen's University Belfast, Belfast, United Kingdom.

Ling Jin (L)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Centre, Sun Yat-sen University, Guangzhou, Guangdong Province, China.

Wenyong Huang (W)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Centre, Sun Yat-sen University, Guangzhou, Guangdong Province, China.

Xiuqin Wang (X)

Department of Ophthalmology, Hospital of Guangdong Medical University, Zhanjiang, Guangdong Province, China.

Tingting Chen (T)

Department of Ophthalmology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong Province, China.

Wenhui Zhu (W)

Department of Ophthalmology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong Province, China; State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Centre, Sun Yat-sen University, Guangzhou, Guangdong Province, China.

Baixiang Xiao (B)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Centre, Sun Yat-sen University, Guangzhou, Guangdong Province, China.

Jun Wang (J)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Centre, Sun Yat-sen University, Guangzhou, Guangdong Province, China.

Zhongqiang Zhou (Z)

Department of Ophthalmology, Henan Provincial People's Hospital, Zhengzhou, Henan Province, China.

Zhizheng Tang (Z)

Department of Ophthalmology, Gaozhou Traditional Chinese Medicine Hospital, Maoming, Guangdong Province, China.

Yan Liang (Y)

Department of Ophthalmology, Xinyi Traditional Chinese Medicine Hospital, Maoming, Guangdong Province, China.

Mabel Crescioni (M)

University of Arizona, Department of Ophthalmology and Vision Science, Tucson, Arizona.

David Wilson (D)

Brien Holden Vision Institute, Sydney, Australia.

Helen McAneney (H)

Centre for Public Health, Queen's University Belfast, Belfast, United Kingdom.

Joshua D Silver (JD)

Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, United Kingdom; Centre for Vision in the Developing World Charitable Foundation, St. Catherine's College, Oxford, United Kingdom.

Bruce Moore (B)

New England College of Optometry, Boston, Massachusetts.

Nathan Congdon (N)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Centre, Sun Yat-sen University, Guangzhou, Guangdong Province, China; Centre for Public Health, Queen's University Belfast, Belfast, United Kingdom. Electronic address: ncongdon1@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH